Medtech innovators invited to pitch at ESIF 2025

AusBiotech

Medtech entrepreneurs are invited to showcase their innovations at the 2025 Early-Stage Innovation Forum (ESIF), a premier platform for emerging developers to present their cutting-edge solutions at the AusMedtech 2025 conference in Sydney 6 – 8 May.

The ESIF rapid-fire pitch competition offers a unique opportunity for innovators to pitch their early-stage medtech technologies to a panel of industry experts, receiving valuable feedback to prepare them for the capital-raising journey ahead.

This exclusive event focuses on projects and technologies in medical devices, diagnostics, digital health, and enabling technologies. It allows innovators to gain insights from a panel of industry experts, corporate VCs, and early-stage investors, helping them refine their approach to commercialization and secure the capital needed to succeed.

Each presenter will have seven minutes to outline the problem their technology addresses, their innovative solution, the competitive advantages of their technology, their development plan, and investment proposal. Successful applicants will receive one (Wednesday Day Pass) registration for the presenter.

For companies that have moved beyond seed funding, there’s an additional opportunity to express interest in AusMedtechInvest 2025, Australia’s premier boutique medtech investment roundtable. This forum is designed to foster personal connections between innovative medtech companies and investors, helping to attract the capital required to thrive in a fast-moving, competitive market. Investors are also invited to apply for a complementary pass.

For more details and to apply for the Early-Stage Innovation Forum, visit the website.